LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 199 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,421,087 | +0.2% | 107,161 | +20.6% | 0.00% | 0.0% |
| Q2 2023 | $6,405,941 | +6.0% | 88,848 | +8.2% | 0.00% | 0.0% |
| Q1 2023 | $6,041,263 | +21.8% | 82,127 | +10.6% | 0.00% | 0.0% |
| Q4 2022 | $4,961,036 | -41.1% | 74,267 | -24.1% | 0.00% | 0.0% |
| Q3 2022 | $8,427,000 | +25.3% | 97,858 | +29.8% | 0.00% | 0.0% |
| Q2 2022 | $6,725,000 | -51.8% | 75,373 | -39.3% | 0.00% | 0.0% |
| Q1 2022 | $13,966,000 | +6.1% | 124,166 | +45.7% | 0.00% | 0.0% |
| Q4 2021 | $13,168,000 | +21.5% | 85,246 | +9.6% | 0.00% | 0.0% |
| Q3 2021 | $10,836,000 | +0.7% | 77,776 | -5.1% | 0.00% | 0.0% |
| Q2 2021 | $10,756,000 | -8.2% | 81,986 | +6.7% | 0.00% | 0.0% |
| Q1 2021 | $11,719,000 | -47.2% | 76,873 | -65.5% | 0.00% | -66.7% |
| Q4 2020 | $22,188,000 | +5.1% | 223,106 | +0.8% | 0.00% | 0.0% |
| Q3 2020 | $21,104,000 | +17.2% | 221,402 | +37.5% | 0.00% | 0.0% |
| Q2 2020 | $18,007,000 | +94.1% | 160,986 | +26.2% | 0.00% | +50.0% |
| Q1 2020 | $9,276,000 | -80.0% | 127,548 | -71.3% | 0.00% | -66.7% |
| Q4 2019 | $46,271,000 | +62.3% | 443,662 | +54.9% | 0.01% | +50.0% |
| Q3 2019 | $28,512,000 | +81.0% | 286,442 | +107.5% | 0.00% | +100.0% |
| Q2 2019 | $15,755,000 | -18.3% | 138,014 | -10.0% | 0.00% | -33.3% |
| Q1 2019 | $19,288,000 | +26.6% | 153,429 | +36.7% | 0.00% | +50.0% |
| Q4 2018 | $15,231,000 | -31.3% | 112,235 | +39.0% | 0.00% | -33.3% |
| Q3 2018 | $22,162,000 | +1.2% | 80,736 | -23.6% | 0.00% | -25.0% |
| Q2 2018 | $21,900,000 | -58.4% | 105,714 | -66.8% | 0.00% | -55.6% |
| Q1 2018 | $52,605,000 | -22.9% | 318,502 | -36.1% | 0.01% | -18.2% |
| Q4 2017 | $68,250,000 | -46.9% | 498,430 | -47.2% | 0.01% | -45.0% |
| Q3 2017 | $128,558,000 | +103.4% | 944,241 | +81.3% | 0.02% | +53.8% |
| Q2 2017 | $63,219,000 | +1.2% | 520,740 | -11.8% | 0.01% | +8.3% |
| Q1 2017 | $62,474,000 | +9.0% | 590,271 | +4.7% | 0.01% | 0.0% |
| Q4 2016 | $57,290,000 | +7.3% | 563,820 | +7.8% | 0.01% | 0.0% |
| Q3 2016 | $53,392,000 | +36.4% | 523,139 | +59.5% | 0.01% | +33.3% |
| Q2 2016 | $39,131,000 | +9.5% | 328,080 | -1.7% | 0.01% | 0.0% |
| Q1 2016 | $35,750,000 | +8.9% | 333,824 | +10.2% | 0.01% | +12.5% |
| Q4 2015 | $32,836,000 | +13.7% | 302,858 | -10.2% | 0.01% | +14.3% |
| Q3 2015 | $28,875,000 | -43.4% | 337,122 | -33.4% | 0.01% | -58.8% |
| Q2 2015 | $51,042,000 | +22.3% | 505,875 | -6.5% | 0.02% | +21.4% |
| Q1 2015 | $41,726,000 | +55.4% | 541,125 | +7.2% | 0.01% | +40.0% |
| Q4 2014 | $26,858,000 | +28.3% | 504,738 | +13.3% | 0.01% | +42.9% |
| Q3 2014 | $20,929,000 | +525.5% | 445,372 | +729.0% | 0.01% | – |
| Q2 2014 | $3,346,000 | +34.4% | 53,725 | +45.2% | 0.00% | – |
| Q1 2014 | $2,489,000 | +19.8% | 37,006 | -6.3% | 0.00% | – |
| Q4 2013 | $2,078,000 | +92.8% | 39,509 | +58.7% | 0.00% | – |
| Q3 2013 | $1,078,000 | +66.6% | 24,893 | +43.7% | 0.00% | – |
| Q2 2013 | $647,000 | – | 17,327 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |